FDA advisers back GSK's OTC nicotine oral spray

23 September 2019 - Deborah Wilkes

Premium

Advisers to the US Food and Drug Administration (FDA) have recommended that GlaxoSmithKline (GSK) Consumer Healthcare's nicotine oral spray can be marketed as an OTC product.

Click tags below for more information on topics:

GlaxoSmithKline FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: